Question 1

How big is the pharmacovigilance & drug safety software industry?

Accepted Answer

Pharmacovigilance and drug safety software market size was USD 171.7 million in 2022 and will register USD 319.9 million by end of 2032 due to the rising number of adverse drug reactions (ADRs) and the presence of stringent guidelines by government and regulatory bodies.

Question 2

Why is the adoption of on-demand/cloud-based (SaaS) pharmacovigilance & drug safety software gaining traction?

Accepted Answer

The on-demand/cloud-based (SaaS) mode of delivery segment held 56.7% share of the  market in 2022 owing to the surging need for enhanced accessibility, seamless scalability, and reduced infrastructure costs.

Question 3

What is the pharmacovigilance & drug safety software industry worth in North America?

Accepted Answer

North America held 37.4% of the pharmacovigilance and drug safety software market share in 2022 owing to the surging demand for efficient and reliable drug safety solutions worldwide.

Question 4

Which are the key pharmacovigilance & drug safety software companies?

Accepted Answer

Arisglobal, AB Cube S.A.S., Extedo GMBH, Ennov Solutions Inc., United BioSource Corporation, Oracle Corporation, Online Business, Applications Inc., United Biosource Corporation, Genepact, and Umbra Global are some of the major pharmacovigilance and drug safety software industry players.

Pharmacovigilance and Drug Safety Software Market Share

Pharmacovigilance & Drug Safety Software Market Share

Premium Report Details

Industries

Information

Link

Global Headquarters